A new study has sparked interest in a question many women might want answered: could hormone replacement therapy (HRT), commonly used to ease menopausal symptoms, help protect against dementia? Researchers found that women who used HRT were less likely to be diagnosed with dementia over time, especially those who had undergone surgery involving their reproductive organs. However, the study does not prove that HRT directly prevents dementia — it only shows a link that needs further investigation. The research analyzed data from 183,450 postmenopausal women in the UK Biobank, tracking them for an average of 13.3 years. During this time, 3,948 women received a dementia diagnosis, with 1,993 of those cases being Alzheimer’s disease. Women who had used HRT for at least a year or were still using it when they joined the study had a 10% lower relative risk of dementia compared to those who didn’t use HRT. This was after adjusting for factors like age, education, smoking, income, blood pressure, and diabetes. The protective effect was more pronounced among women who had a "surgical menopause" — meaning they had surgery to remove their womb or ovaries. For this group, HRT use was linked to a 26% lower relative risk of dementia. However, this group included women who had different types of surgery. Removing both ovaries causes a sudden drop in estrogen, a hormone that declines naturally during menopause. In contrast, removing the womb alone does not always lead to a sharp drop in estrogen. This makes it harder to determine if HRT’s benefits are specifically tied to replacing estrogen lost through surgery. It is also possible that women who take HRT differ from those who don’t in ways that influence dementia risk. Factors like education, income, general health, and access to care can affect both the decision to use HRT and long-term health outcomes. While researchers can adjust for known differences, they can’t account for every variable. Earlier studies have shown that women who later chose HRT were already healthier and had a lower dementia risk years before starting treatment — suggesting that other factors might be at play. The new study did not look at whether HRT users took estrogen alone or in combination with another hormone called progestogen, nor did it compare different doses or ways of taking HRT. Other research has suggested that longer use of combined hormone therapy may slightly increase Alzheimer’s risk, but this is not seen with estrogen-only treatment. These findings are also from observational studies, meaning they cannot prove that HRT caused the effects. Results from the same UK Biobank data have been mixed. An earlier analysis suggested that long-term HRT use might be linked to a higher dementia risk in women who experienced natural menopause after age 50. However, these studies asked different questions and looked at different groups, so they cannot be directly compared. The varying results highlight the complexity of the issue and why one new finding does not settle the debate. The study also hints that the timing of HRT use may matter. Women who started HRT between their late forties and mid-fifties showed a lower dementia risk, but this pattern was less clear in those who started earlier. This makes it hard to argue that starting HRT as early as possible protects those who experience menopause at a young age. Researchers also looked at women with a genetic variant called APOE ε4, which is linked to a higher risk of Alzheimer’s. While the protective effect of HRT seemed stronger in these women, the results were not statistically strong enough to confirm this. Previous studies on this topic have also produced conflicting results. Trials in women closer to menopause have not shown consistent improvements in memory or thinking after several years of HRT. Some short-term studies have found benefits, especially for women with severe menopausal symptoms, but these do not prove that HRT prevents dementia. A trial in women aged 65 and older found a higher rate of dementia among those using a common form of combined HRT at the time, but this doesn’t fully address current treatment practices or the needs of women who experience early surgical menopause. Currently, medical guidelines, such as those from the National Institute for Health and Care Excellence (NICE), do not recommend HRT specifically to prevent dementia or heart disease. Instead, HRT is advised for managing menopausal symptoms like hot flushes and night sweats, with decisions based on individual health, risks, and benefits. For now, the study does not provide enough evidence to change HRT use solely to prevent dementia. However, it does highlight the need for further research, especially for women who experience early loss of hormones due to surgery.